WeightWatchers gets a makeover with obesity-drug business | Curio
News and insights read out for you.
10,000+ audio articles. 30+ world-leading publications.

All in 1 subscription.

The Wall Street Journal logo

WeightWatchers gets a makeover with obesity-drug business

5 mins | Jun 1, 2023
story image

Obesity medications such as Ozempic are becoming some of the most profitable drugs in the pharmaceutical industry. With companies struggling to keep up with demand, David Wainer explains why getting into the business of weight loss drugs makes financial sense for WeightWatchers.

Get unlimited access free for 7 days, then $16.66/month (billed annually)
Get started